Condition: Toxoplasmosis · Sponsor: Assistance Publique - Hôpitaux de Paris
Toxoplasmosis is a common infection whose clinical severity can sometimes justify admission to intensive care, especially in immunocompromised patients. This study should make it possible to evaluate the impact of different anti-infective treatment regimens and to highlight clinical-biological and prognostic differences depending on the type of underlying immunosuppression.
This description comes directly from the study's public registry record.
Clara Vigneron, MD · 06 33 14 56 50 · clara.vigneron@aphp.fr
Romain Sonneville, MD, PhD · 01 40 25 61 39 · romain.sonneville@aphp.fr
Always discuss trial participation with your own doctor first.
| Cochin hospital | Paris, France, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06305468